CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Novel predictors of late lumen enlargement in distal reference segments after successful recanalization of coronary chronic total occlusion Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trial. Short-Term Progression of Multiterritorial Subclinical Atherosclerosis Sex differences in left main coronary artery stenting: Different characteristics but similar outcomes for women compared with men The Year in Cardiovascular Medicine 2020: Imaging: Looking back on the Year in Cardiovascular Medicine for 2020 in the field of imaging are Fausto Pinto, José Luis Zamorano and Chiara Bucciarelli-Ducci. Judy Ozkan speaks with them Usefulness of minimum stent cross sectional area as a predictor of angiographic restenosis after primary percutaneous coronary intervention in acute myocardial infarction (from the HORIZONS-AMI Trial IVUS substudy) Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes Lateral Wall Dysfunction Signals Onset of Progressive Heart Failure in Left Bundle Branch Block
|<<... 96 97 98 99 100 101 102 ...>>|

Original Research2021 Jan 5;1-10.

JOURNAL：J Natl Compr Canc Netw. Article Link

Risk of Cardiovascular Diseases Among Older Breast Cancer Survivors in the United States: A Matched Cohort Study

AA Matthews, SP Hinton, S Stanway et al. Keywords: breast cancer; CVD; screening and monitoring

Full Text PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top